A Phase 1b Trial of CB-839 in Combination with Radiation Therapy and Temozolomide in Patients with IDH-mutated Diffuse Astrocytoma and Anaplastic Astrocytoma

IRB/UVA Tracking #
21792
Contact
Contact Phone
Cancer PI
David Schiff
Status
OPEN TO ACCRUAL
Ages
Adult